Oct 3, 2022
When treatment options run out in China, some patients turn to the U.S., where clinical trials unavailable at home offer a potential and affordable lifeline.
Click here to read the article by Shi Yonggang, the former chief editor of iFeng Weekly magazine.
Narrated by Elyse Ribbons.
Are you a big fan of our shows? Then please give our
podcast account, China Business Insider, a 5-star rating on
Spotify, Apple, or wherever you listen to podcasts